Subscribe here to receive the latest news and stories to your inbox.
Be inspired by our supporters; read the latest issue of Lifeblood.
Resources for media personnel, including facts and statistics on blood cancer; media contacts; and guidelines for reporting on blood cancer in Australia.
As Perry Judd slowly pedalled over the finishing line at the prestigious Grafton to Inverell Cycle Classic in 2013, supposedly in the form of his life but somehow lagging far behind the competition, he knew something wasn’t right. Physically exhausted, Perry feared he had glandular fever, but a blood test revealed something much more dangerous. The then 37-year-old explained: “I had a call from the GP: ‘Please come and see me, we need to talk urgently. You need to come in right away’.
The Leukaemia Foundation today unveiled a powerful addition to its team of Ambassadors, the Honourable Anna Bligh AC. As the former Premier of Queensland and current CEO of the Australian Banking Association, Ms Bligh is a survivor of the blood cancer Non-Hodgkin lymphoma, after being diagnosed in 2013. Ms Bligh will immediately step into her role as National Ambassador, bringing with her a wealth of experience to passionately advocate for fellow Australians impacted by blood cancer.
Join Kate Arkadieff and Theresa Webb as they delve into non-Hodgkin's lymphoma & acute lymphoblastic leukaemia (leukemia) journeys for patients and families on the Talking Blood Cancer podcast by Leukaemia Foundation.
It’s the number one challenge of people with cancer in Australia , yet ‘cancer related fatigue’ is the often-unspoken side effect that drains and debilitates thousands of Australians every day. With approximately one in two cancer patients reportedly experiencing moderate to severe fatigue during treatment , and for many in the years following, the Leukaemia Foundation believes the prevalence of cancer related fatigue could be much higher.
Discover how physiotherapist Julie Allen tackles cancer fatigue and lymphoma, enhancing the quality of life and survival for blood cancer patients.
In the ever-evolving landscape of blood cancer research, the quest to combat blood cancer continues to push boundaries. The New Directions in Leukaemia Research (NDLR) event in Adelaide last month brought together leading minds in the field to discuss breakthroughs, challenges, and the future of leukaemia treatment. From cutting-edge advancements in therapies to the promise of personalised medicine, the conference, sponsored by the Leukaemia Foundation, shed light on the latest discoveries and strategies shaping the fight against leukaemia.
